Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (41-50 of 272) with videos related to

Pageof 28
Sort By:
Current Medical Research and Opinion|February 1, 2026
A plain language summary: long-term safety and effectiveness of atacicept in individuals with IgA nephropathyJonathan Barratt, Kelly Chen, Richard Lafayette
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2022
Clinical application of microRNAs in glomerular diseasesHaresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
BMJ Open|April 2, 2021
Multimethods study comparing the experiences of medical clinical academics with nurses, midwives and allied health professionals pursuing a clinical academic careerDiane Trusson, Emma Rowley, Jonathan Barratt
Clinical Kidney Journal|February 10, 2018
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?Haresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
Seminars in Nephrology|September 5, 2018
Treatment of IgA Nephropathy: Evolution Over Half a CenturyJonathan Barratt, Sydney C W Tang
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2007
A spoonful of sugar helps the proteinuria go down?Peter Topham, Jonathan Barratt, John Feehally
International Journal of Immunogenetics|November 25, 2021
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney linkHaresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Nephrology (Carlton, Vic.)|June 3, 2015
Emerging therapies in immunoglobulin A nephropathySee Cheng Yeo, Adrian Liew, Jonathan Barratt
Seminars in Nephrology|May 25, 2004
Pathogenesis of IgA nephropathyJonathan Barratt, John Feehally, Alice C Smith
The New England Journal of Medicine|May 13, 2026
Targeting CD20 versus APRIL or BAFF and APRIL for IgA Nephropathy. ReplyRichard Lafayette, Robert M Brenner, Jonathan Barratt
Pageof 28

Showing results (41-50 of 272) with videos related to

Sort By:
Pageof 28
Current Medical Research and Opinion|February 1, 2026
A plain language summary: long-term safety and effectiveness of atacicept in individuals with IgA nephropathyJonathan Barratt, Kelly Chen, Richard Lafayette
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2022
Clinical application of microRNAs in glomerular diseasesHaresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
BMJ Open|April 2, 2021
Multimethods study comparing the experiences of medical clinical academics with nurses, midwives and allied health professionals pursuing a clinical academic careerDiane Trusson, Emma Rowley, Jonathan Barratt
Clinical Kidney Journal|February 10, 2018
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?Haresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
Seminars in Nephrology|September 5, 2018
Treatment of IgA Nephropathy: Evolution Over Half a CenturyJonathan Barratt, Sydney C W Tang
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2007
A spoonful of sugar helps the proteinuria go down?Peter Topham, Jonathan Barratt, John Feehally
International Journal of Immunogenetics|November 25, 2021
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney linkHaresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Nephrology (Carlton, Vic.)|June 3, 2015
Emerging therapies in immunoglobulin A nephropathySee Cheng Yeo, Adrian Liew, Jonathan Barratt
Seminars in Nephrology|May 25, 2004
Pathogenesis of IgA nephropathyJonathan Barratt, John Feehally, Alice C Smith
The New England Journal of Medicine|May 13, 2026
Targeting CD20 versus APRIL or BAFF and APRIL for IgA Nephropathy. ReplyRichard Lafayette, Robert M Brenner, Jonathan Barratt
Pageof 28